Literature DB >> 18040808

Effects of inhalant nitrites on VEGF expression: a feasible link to Kaposi's sarcoma?

Ho-Leung Fung1, Doanh C Tran.   

Abstract

Because inhalant nitrites (commonly known as "poppers") were thought to be rapidly cleared from the body, the lay literature has somewhat downplayed their toxicity. However, scientific reports have documented their immunosuppressive effects in animals, and epidemiological studies have implicated their use with the development of Kaposi's sarcoma (KS) in humans. Because inhalant nitrites are exogenous nitric oxide donors, we hypothesized that these substances of abuse might exert part of their toxicological effects through this biochemical product, which has been shown to alter gene regulation and angiogenesis. In a series of studies, we showed that acute and chronic in vivo exposure to isobutyl nitrite (a representative inhalant nitrite) produced significant tissue-dependent alterations in the expression of a number of cancer- and angiogenesis-related genes in mice. In particular, hepatic mRNA and protein expression of vascular endothelial growth factor (VEGF) was significantly stimulated. The in vivo growth rate of a subcutaneous VEGF-responsive tumor was also shown to be accelerated by inhalant nitrite exposure. Because the development of KS is extensively linked to VEGF and its receptors, the purported link between inhalant nitrites and KS may be explained mechanistically, at least in part, through the stimulation of VEGF expression by these inhalants.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18040808     DOI: 10.1007/s11481-006-9024-4

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  33 in total

1.  Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.

Authors:  T A Partanen; K Alitalo; M Miettinen
Journal:  Cancer       Date:  1999-12-01       Impact factor: 6.860

2.  Use of nitrite inhalants ("poppers") among American youth.

Authors:  Li-Tzy Wu; William E Schlenger; Chris L Ringwalt
Journal:  J Adolesc Health       Date:  2005-07       Impact factor: 5.012

3.  Butyl nitrite in the induction of Kaposi's sarcoma in AIDS.

Authors:  S S Mirvish; H W Haverkos
Journal:  N Engl J Med       Date:  1987-12-17       Impact factor: 91.245

4.  Risk factors for Kaposi's sarcoma in the Vancouver Lymphadenopathy-AIDS Study.

Authors:  C P Archibald; M T Schechter; K J Craib; T N Le; B Douglas; B Willoughby; M O'Shaughnessy
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

5.  Effects of repeated in vivo inhalant nitrite exposure on gene expression in mouse liver and lungs.

Authors:  Doanh C Tran; Daniel A Brazeau; Peter A Nickerson; Ho-Leung Fung
Journal:  Nitric Oxide       Date:  2005-11-08       Impact factor: 4.427

6.  Pharmacokinetics of a model organic nitrite inhalant and its alcohol metabolite in rats.

Authors:  W Kielbasa; H L Fung
Journal:  Drug Metab Dispos       Date:  2000-04       Impact factor: 3.922

7.  Nitrite inhalation in rats elevates tissue NOS III expression and alters tyrosine nitration and phosphorylation.

Authors:  W Kielbasa; H L Fung
Journal:  Biochem Biophys Res Commun       Date:  2000-08-28       Impact factor: 3.575

8.  T cell functions are impaired by inhaled isobutyl nitrite through a T-independent mechanism.

Authors:  L S Soderberg
Journal:  Toxicol Lett       Date:  1994-02-15       Impact factor: 4.372

9.  Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus.

Authors:  J J Goedert; R J Biggar; M Melbye; D L Mann; S Wilson; M H Gail; R J Grossman; R A DiGioia; W C Sanchez; S H Weiss
Journal:  JAMA       Date:  1987-01-16       Impact factor: 56.272

Review 10.  Volatile nitrites. Use and adverse effects related to the current epidemic of the acquired immune deficiency syndrome.

Authors:  G R Newell; P W Mansell; M R Spitz; J M Reuben; E M Hersh
Journal:  Am J Med       Date:  1985-05       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.